RxDoctor Payments Data

Gina Luciano

Adult Health · Greenvale, NYNPI 1821860230

Payments from drug & device makers

$2,407in general payments, 2019–2025

Across 117 payments — averaging $20.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$480
  • Novartis$414
  • Amgen$337
  • Exact Sciences$170
  • Lilly USA, LLC$133
  • Pfizer$128
  • plus $745 from 15 others

What the payments were for

  • Food & beverage$2,31096%
  • Education$974%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,407 in reported general payments places this provider in the 80th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Medicare billing

Part B allowed, 2024
$4,683
Medicare patients
36
Services billed
59

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
DificidFidaxomicin11$53,909
OzempicSemaglutide29$41,788
MounjaroTirzepatide32$39,985
XareltoRivaroxaban26$36,600
EliquisApixaban39$34,353
Repatha SureclickEvolocumab23$28,732
TradjentaLinagliptin12$16,667
AmbienZolpidem Tartrate11$14,260
JardianceEmpagliflozin13$13,366
Breo ElliptaFluticasone/Vilanterol21$10,565
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$7,140
Lantus SolostarInsulin Glargine,hum.Rec.Anlog26$2,655
Atorvastatin Calcium185$2,311
Pantoprazole Sodium106$1,877
Metoprolol Succinate106$1,870

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckDificid$75$53,90911 claims
Novo NordiskOzempic$480$41,78829 claims
Lilly USA, LLCMounjaro$133$39,98532 claims
PfizerEliquis$128$34,35339 claims
Boehringer IngelheimTradjenta, Jardiance$51$30,03325 claims
AbbVieSynthroid$22$1,08323 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,828 adult health providers in New York.

Other adult health in Greenvale

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →